Printer Friendly

BARR REINTRODUCES THREE ANTIBIOTICS

 POMONA, N.Y., Aug. 30 /PRNewswire/ -- Barr Laboratories, Inc. (AMEX: BRL), announced the reintroduction of three important antibiotic products, Cephalexin for Oral Suspension 125mg/5ml and Cephalexin for Oral suspension 250mg/5ml, generic equivalents to Dista's Keflex(R), and Erythromycin Ethylsuccinate for Oral Suspension 200 mg/5ml, a generic equivalent to Abbott Laboratories' E.E.S. Granules(R).
 The two Cephalexin for Oral Suspension products join Barr Laboratories' expanding line of Cephalexin products. Both Cephalexin products are available for immediate shipment in bottles of 100ml and 200ml. Barr currently manufactures and distributes Cephalexin Capsules in 250mg and 500mg strengths, and Cephalexin Tablets 250mg.
 Erythromycin Ethylsuccinate for Oral Suspension 200mg/5ml, available in bottles of 100ml and 200ml, is an important addition to Barr's expanding Erythromycin product line. Earlier this year, Barr reintroduced E.S.P.(R), (Erythromycin Ethylsuccinate and Sulfisoxazole Acetyl), a generic equivalent to Ross Laboratories' Pediazole(R).
 Barr and the FDA agree that the additional studies completed for Cephalexin for Oral Suspension 125mg/5ml, Cephalexin for Oral Suspension 250mg/5ml and Erythromycin Ethylsuccinate for Oral Suspension 200mg/5ml satisfy the FDA's validation requirements. The company expects to reintroduce additional products over the coming weeks.
 The three new product reintroductions account for approximately $1 million in sales on an annualized basis and brings the number of reintroductions to a total of seven.
 Barr Laboratories is a manufacturer of a broad range of generic pharmaceutical products with manufacturing facilities located in Northvale, N.J., and Pomona.
 -0- 8/30/93
 /CONTACT: Harold Cohen of Barr Laboratories, 914-362-2823/
 (BRL)


CO: Barr Laboratories, Inc. ST: New York IN: MTC SU: PDT

LD -- NY020 -- 6940 08/30/93 08:58 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 30, 1993
Words:278
Previous Article:ECOGEN NAMES LEADING ENTOMOLOGIST AS DIRECTOR OF NEMATODE RESEARCH
Next Article:ALDUS ANNOUNCES FETCH 1.2
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters